POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 87 | / | 2017 | ||||||||
Date of issue: | 2017-09-19 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Current report 87 re insiders transactions | |||||||||||
Official market - legal basis | |||||||||||
art. 17. 1 MAR. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
„Sopharma” AD (the Company) announces that it was notified by „Donev Investments Holding” AD related to Ognian Ivanov Donev, that „Donev Investments Holding” AD executed the following transactions related to shares in the Company: Date and time of the transaction Operation Number of shares Unit price (BGN) 14.09.2017 Buy 151 4.410 15.09.2017 Buy 200 4.380 15.09.2017 Buy 500 4.330 18.09.2017 Buy 3 000 4.280 18.09.2017 Buy 1 312 4.230 18.09.2017 Buy 180 4.230 18.09.2017 Buy 1 000 4.230 18.09.2017 Buy 1 508 4.230 18.09.2017 Buy 382 4.220 18.09.2017 Buy 5 218 4.220 18.09.2017 Buy 2 000 4.210 18.09.2017 Buy 1 272 4.200 18.09.2017 Buy 4 328 4.200 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report 87 re insiders transactions.doc | Current report 87 re insiders transactions |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2017-09-19 | Ognian Donev | Executive director |